The diverse network of interactions shown for SKIP, in particular with nuclear hormone receptors, explains its impact on several signalling pathways involved in growth and development, including possibly in AR-dependent prostate cancer cell growth. This evidence concerns the gene NR0B1 and prostate carcinoma.